Convicted financier Jeffrey Epstein funded genetic testing to potentially extend life through regenerative medicine, as revealed by recently disclosed emails.
Newly released emails from the Epstein files indicate that convicted sex offender Jeffrey Epstein financed genetic testing as ...
Combining genetic, structural, and digital innovations can provide an opportunity to develop climate-resilient cereals that ...
As investigations into Epstein’s network persist, including scrutiny of associates like Ghislaine Maxwell, convicted in 2021 ...
Epstein paid for novel genetic testing in apparent effort to explore extending life, new emails show
Convicted sex offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his own genetic material for ...
Researchers reprogrammed bacterial bridge recombinases to edit large genomic regions in mammalian cells, revealing a ...
Nobel laureate Jennifer Doudna, PhD; Matthew Porteus, MD, PhD, and Rodolphe Barrangou, PhD—offer their views on the commercial potential and challenges of genome editing following a rollercoaster 2025 ...
Inside the lab where scientists want to rewrite our DNA from scratch - Artificial biological intelligence could change ...
Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programsVispa-cel ...
OGM was selected as a genome-wide, unbiased method to detect large genomic rearrangements and structural variants (SVs) with sensitivity to variant allele fractions (VAFs) as low as 5% to analyze ...
Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.
Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru crafted a bespoke treatment that has successfully corrected the genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results